<DOC>
	<DOCNO>NCT01367886</DOCNO>
	<brief_summary>This study do evaluate use new technology ( urine proteomics ) - study proteins urine identify urine marker overactive bladder ( OAB ) simple void urine specimen .</brief_summary>
	<brief_title>Comparative Urine Proteomic Studies Overactive Bladder Humans</brief_title>
	<detailed_description>The objective study : 1. improve diagnosis overactive bladder use non-invasive technology ( urine proteomics ) 2. study potential urine biomarkers change overactive bladder symptom patient treated fesoterodine , FDA approve drug treatment overactive bladder .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>For healthy volunteer inclusion criterion : 1 . Females ≥ 18 year old 2 . Not experience overactive bladder symptom 3 . Not experience frequency urgency For overactive bladder patient inclusion criterion 1 . Females ≥ 18 year old 2 . Overactive bladder symptom ≥ 3 month screen ) Recurrent urinary tract infection ( UTIS ) &gt; 3/year For healthy volunteer exclusion criterion : 1 . Overactive bladder symptom , frequency urgency 2 . Intermittent/unstable use bladder medication 3 . Pregnant woman woman unwilling use contraceptives 4 . Neurological condition : stroke , Multiple Sclerosis ( MS ) , Parkinson 's , spinal cord injury 5 . Significant pelvic organ prolapse ( grade 3 base physical exam ) 6 . Lower urinary tract surgery within past 6 month 7 . Known history IC pain associate OAB 8 . Urinary retention require catheterization , indwell catheter Selfcath 9 . Recurrent UTIS &gt; 3/year For overactive bladder patient exclusion criterion : 1 . Contraindications Fesoterodine use hypersensitivity , GI urinary retention , Glaucoma 2 . Intermittent/unstable use bladder medication 3 . Pregnant woman woman unwilling use contraceptives 4 . Neurological condition : stroke , MS , Parkinson 's , spinal cord injury 5 . Significant pelvic organ prolapse ( grade 3 base physical exam ) 6 . Lower urinary tract surgery within past 6 month 7 . Known history Interstitial Cystitis ( IC ) pain associate OAB 8 . Urinary retention require catheterization , indwell catheter Selfcath 9 . Recurrent urinary tract infection ( UTIS ) &gt; 3/year Deferral Criteria : Treatment OAB medication within 2 week baseline visit . If patient currently OAB medication patient ask stop OAB medication 2 week return baseline visit .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Urine proteomics</keyword>
	<keyword>overactive bladder</keyword>
</DOC>